Ixekizumab Provides Improvements through 52 Weeks in Physical Function, Quality of Life, and Work Productivity in Biologic DiseaseModifying Antirheumatic Drug-Naive Patients with Active Psoriatic Arthritis

被引：0
|
作者：
Gottlieb, Alice [1 ]
Husni, Elaine [2 ]
Shuler, Catherine [3 ]
Burge, Russel [3 ]
Lin, Chen-Yen [3 ]
Lee, Chin [3 ]
Gladman, Dafna [4 ]
机构：
[1] New York Med Coll, Valhalla, NY 10595 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
[3] Eli Lilly & Co, Indianapolis, IN 46285 USA
[4] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2017年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
175
引用
收藏
页码：924 / 925
页数：2
相关论文
共 50 条
  • [31] SUSTAINED IMPROVEMENTS IN PHYSICAL FUNCTION, QUALITY OF LIFE, AND WORK PRODUCTIVITY WITH IXEKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND PREVIOUS INADEQUATE RESPONSE TO TUMOUR NECROSIS FACTOR-INHIBITORS: 3-YEAR RESULTS FROM SPIRIT-P2 TRIAL
    Orbai, A. M.
    Gratacos-Masmitja, J.
    Dokoupilova, E.
    Combe, B.
    Constantin, A.
    Gellett, A. M.
    Sprabery, A. T.
    Birt, J.
    Geneus, V.
    Nash, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1705 - 1706
  • [32] SECUKINUMAB SIGNIFICANTLY IMPROVES PHYSICAL FUNCTION, QUALITY OF LIFE, AND WORK PRODUCTIVITY THROUGH 52 WEEKS IN SUBJECTS WITH ACTIVE ANKYLOSING SPONDYLITIS IN THE PHASE 3 MEASURE 2 STUDY
    Deodhar, A.
    Sieper, J.
    Emery, P.
    Porter, B.
    Andersson, M.
    Richards, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1144 - 1144
  • [33] SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND HEALTH RELATED QUALITY OF LIFE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM FUTURE 1 AND FUTURE 2
    Strand, V.
    FitzGerald, O.
    Coates, L. C.
    Walsh, J. A.
    Canete, J. D.
    Bhosekar, V.
    Pricop, L.
    Gandhi, K.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 688 - 688
  • [34] Bimekizumab Efficacy and Safety in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients With Psoriatic Arthritis Was Consistent With or Without Methotrexate: 52-Week Results From the Phase 3 ActiveReference Study Be Optimal
    Gladman, Dafna
    McInnes, Iain
    Mease, Philip
    Tanaka, Yoshiya
    Behrens, Frank
    Gossec, Laure
    Husni, Elaine
    Kristensen, Lars
    Warren, Richard
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Eells, Jason
    Gottlieb, Alice
    JOURNAL OF RHEUMATOLOGY, 2024, 51 : 19 - 19
  • [35] Rapid and sustained improvements in cutaneous and musculo-skeletal signs and symptoms with 108 weeks treatment of ixekizumab in psoriatic arthritis in biologic-naive and TNF-inadequate responder patients
    Gottlieb, Alice B.
    Merola, Joseph F.
    Shrom, David
    Sprabery, Aubrey T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB262 - AB262
  • [36] GUSELKUMAB PROVIDES SUSTAINED IMPROVEMENTS IN HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 2 YEARS OF DISCOVER-2
    Curtis, J.
    McInnes, I.
    Rahman, P.
    Gladman, D. D.
    Yang, F.
    Peterson, S.
    Kollmeier, A.
    Shiff, N.
    Han, C.
    Shawi, M.
    Tillett, W.
    Mease, P. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1563 - 1564
  • [37] Guselkumab Provides Sustained Improvements in Health-Related Quality of Life in Patients with Active Psoriatic Arthritis Through 2 Years of DISCOVER-2
    Curtis, Jeffrey
    McInnes, Iain B.
    Rahman, Proton
    Gladman, Dafna
    Yang, Feifei
    Peterson, Steve
    Kollmeier, Alexa
    Shiff, Natalie
    Han, Chenglong
    Shawi, May
    Tillett, William
    Mease, Philip J.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3651 - 3653
  • [38] Golimumab significantly improves physical function, health-related quality of life, productivity, & reduces time lost from work for Caregivers in patients with active psoriatic arthritis
    Mease, P.
    McInnes, I.
    Krueger, G. G.
    Gladman, D.
    Gomez-Reino, J. J.
    Papp, K.
    Livingston, J.
    Mudivarthy, S.
    Mack, M.
    Beutler, A.
    Parasuraman, S.
    Buchanan, J.
    Han, C.
    Kavanaugh, A.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S574 - S575
  • [39] GUSELKUMAB PROVIDES SUSTAINED IMPROVEMENTS IN WORK PRODUCTIVITY AND NON-WORK ACTIVITY IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS THROUGH 1 YEAR OF A PHASE 3 TRIAL
    Curtis, J.
    Mcinnes, I.
    Peterson, S.
    Agarwal, P.
    Yang, F.
    Kollmeier, A.
    Hsia, E. C.
    Han, C.
    Tillett, W.
    Mease, P. J.
    Rahman, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 782 - 783
  • [40] Efficacy and Safety of Ixekizumab versus Adalimumab with and Without Concomitant Conventional Synthetic Disease-Modifying Antirheumatic Drugs (DMARD) in Biologic DMARD-Naive Patients with Psoriatic Arthritis: 52-Week Results
    Smolen, Josef
    Sebba, Anthony
    Ruderman, Eric
    Gellett, Amanda
    Sapin, Christophe
    Sprabery, Aubrey
    Liu-Leage, Soyi
    Pillai, Sreekumar
    Reis, Paulo
    Nash, Peter
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345